دورية أكاديمية
أعرض في EDS

Polymers in Technologies of Additive and Inkjet Printing of Dosage Formulations.

التفاصيل البيبلوغرافية
العنوان: Polymers in Technologies of Additive and Inkjet Printing of Dosage Formulations.
المؤلفون: Blynskaya EV; V. V. Zakusov Research Institute of Pharmacology, 8 Baltiyskaya St., 125315 Moscow, Russia.; Institute of Biochemical Technology and Nanotechnology, Peoples' Friendship University of Russia (RUDN), 6 Miklukho-Maklaya St., 117198 Moscow, Russia., Tishkov SV; V. V. Zakusov Research Institute of Pharmacology, 8 Baltiyskaya St., 125315 Moscow, Russia., Alekseev KV; V. V. Zakusov Research Institute of Pharmacology, 8 Baltiyskaya St., 125315 Moscow, Russia., Vetcher AA; Institute of Biochemical Technology and Nanotechnology, Peoples' Friendship University of Russia (RUDN), 6 Miklukho-Maklaya St., 117198 Moscow, Russia.; Complementary and Integrative Health Clinic of Dr. Shishonin, 5 Yasnogorskaya St., 117588 Moscow, Russia., Marakhova AI; Institute of Biochemical Technology and Nanotechnology, Peoples' Friendship University of Russia (RUDN), 6 Miklukho-Maklaya St., 117198 Moscow, Russia., Rejepov DT; Institute of Biochemical Technology and Nanotechnology, Peoples' Friendship University of Russia (RUDN), 6 Miklukho-Maklaya St., 117198 Moscow, Russia.
المصدر: Polymers [Polymers (Basel)] 2022 Jun 22; Vol. 14 (13). Date of Electronic Publication: 2022 Jun 22.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101545357 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4360 (Electronic) Linking ISSN: 20734360 NLM ISO Abbreviation: Polymers (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel : MDPI
مستخلص: Technologies for obtaining dosage formulations (DF) for personalized therapy are currently being developed in the field of inkjet (2D) and 3D printing, which allows for the creation of DF using various methods, depending on the properties of pharmaceutical substances and the desired therapeutic effect. By combining these types of printing with smart polymers and special technological approaches, so-called 4D printed dosage formulations are obtained. This article discusses the main technological aspects and used excipients of a polymeric nature for obtaining 2D, 3D, 4D printed dosage formulations. Based on the literature data, the most widely used polymers, their properties, and application features are determined, and the technological characteristics of inkjet and additive 3D printing are shown. Conclusions are drawn about the key areas of development and the difficulties that arise in the search and implementation in the production of new materials and technologies for obtaining those dosage formulations.
References: Vestn Ross Akad Med Nauk. 2012;(12):4-12. (PMID: 23530419)
Int J Pharm. 2013 Jan 30;441(1-2):818-25. (PMID: 23266759)
Int J Pharm. 2014 Dec 10;476(1-2):88-92. (PMID: 25275937)
J Pharm Sci. 2014 Feb;103(2):496-506. (PMID: 24311373)
Eur J Pharm Biopharm. 2015 Oct;96:314-21. (PMID: 26325060)
J Pharm Sci. 2013 Oct;102(10):3694-704. (PMID: 23904182)
Expert Opin Drug Deliv. 2013 Jan;10(1):131-49. (PMID: 23102011)
Curr Pharm Des. 2018;24(42):5062-5071. (PMID: 30767736)
Int J Pharm. 2015 Oct 30;494(2):554-567. (PMID: 25772419)
Chem Rev. 2017 Aug 9;117(15):10212-10290. (PMID: 28756658)
Int J Pharm. 2018 Jul 10;545(1-2):144-152. (PMID: 29705104)
J Pharm Sci. 2011 Aug;100(8):3386-3395. (PMID: 21360709)
Int J Pharm. 2015 Oct 30;494(2):578-584. (PMID: 25683143)
Int J Pharm. 2017 Oct 30;532(1):313-317. (PMID: 28888978)
Int J Pharm. 2014 Jan 1;459(1-2):62-4. (PMID: 24239831)
Sci Rep. 2015 Jun 08;5:11011. (PMID: 26051984)
Int J Pharm. 2015 Dec 30;496(2):414-20. (PMID: 26481468)
Eur J Pharm Sci. 2016 Jul 30;90:53-63. (PMID: 26545484)
Pharm Res. 2011 Oct;28(10):2386-92. (PMID: 21544688)
Int J Pharm. 2017 Mar 15;519(1-2):186-197. (PMID: 28017768)
Sci Rep. 2016 Jun 02;6:27226. (PMID: 27251982)
Polymers (Basel). 2022 Mar 10;14(6):. (PMID: 35335442)
Biomaterials. 2010 Aug;31(24):6121-30. (PMID: 20478613)
Bioengineering (Basel). 2017 Sep 22;4(4):. (PMID: 28952558)
Sci Rep. 2014 Dec 18;4:7422. (PMID: 25522053)
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):67-72. (PMID: 21149682)
Biofabrication. 2011 Sep;3(3):034109. (PMID: 21727312)
Int J Pharm. 2015 Apr 10;483(1-2):244-9. (PMID: 25527212)
Biomacromolecules. 2017 Sep 11;18(9):2669-2687. (PMID: 28762718)
Mol Pharm. 2017 Mar 6;14(3):808-820. (PMID: 28195483)
Biofabrication. 2015 Aug 11;7(3):035006. (PMID: 26260872)
Nanoscale. 2015 Sep 7;7(33):14010-22. (PMID: 26234364)
Int J Pharm. 2016 Feb 29;499(1-2):376-394. (PMID: 26757150)
J Control Release. 2011 Dec 10;156(2):179-85. (PMID: 21827800)
Biomaterials. 2017 Jan;115:115-127. (PMID: 27886552)
ACS Appl Mater Interfaces. 2015 Dec 23;7(50):27613-23. (PMID: 26651013)
Int J Pharm. 2016 Sep 10;511(1):606-618. (PMID: 27444550)
Eur J Pharm Sci. 2015 Feb 20;68:11-7. (PMID: 25460545)
ACS Appl Mater Interfaces. 2017 May 24;9(20):17408-17416. (PMID: 28475310)
Biopolymers. 2012 Feb;97(2):83-93. (PMID: 21830198)
Int J Pharm. 2015 Oct 30;494(2):568-577. (PMID: 25498157)
J Biomed Mater Res B Appl Biomater. 2016 Aug;104(6):1210-9. (PMID: 26089195)
Carbohydr Polym. 2016 Sep 20;149:163-74. (PMID: 27261741)
J Pharm Sci. 2013 Feb;102(2):638-48. (PMID: 23225152)
Polim Med. 2014 Jul-Sep;44(3):189-96. (PMID: 25739125)
ACS Appl Mater Interfaces. 2018 Feb 28;10(8):6841-6848. (PMID: 29322768)
Adv Healthc Mater. 2013 Aug;2(8):1142-50. (PMID: 23386382)
J Pharm Sci. 2012 Jul;101(7):2523-33. (PMID: 22527973)
Int J Pharm. 2016 Jul 25;509(1-2):255-263. (PMID: 27215535)
Anal Chem. 2014 Apr 1;86(7):3240-53. (PMID: 24432804)
Dent Mater. 2016 Jan;32(1):54-64. (PMID: 26494268)
Eur J Pharm Sci. 2018 Mar 30;115:11-18. (PMID: 29305984)
Macromol Rapid Commun. 2017 Jan;38(2):. (PMID: 27918636)
Drug Dev Ind Pharm. 2016;42(7):1019-31. (PMID: 26625986)
AAPS PharmSciTech. 2007 Oct 19;8(4):E86. (PMID: 18181547)
Int J Pharm. 2018 Jan 30;536(1):318-325. (PMID: 29217471)
Nat Mater. 2016 Apr;15(4):413-8. (PMID: 26808461)
Int J Pharm. 2017 Aug 7;528(1-2):268-279. (PMID: 28583328)
Expert Opin Drug Deliv. 2019 Sep;16(9):981-993. (PMID: 31382842)
Int J Pharm. 2015 Oct 30;494(2):611-618. (PMID: 25526674)
Eur J Pharm Biopharm. 2015 Oct;96:380-7. (PMID: 26277660)
Ther Deliv. 2017 Aug;8(9):721-723. (PMID: 28825394)
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1075-83. (PMID: 23563101)
Cell Transplant. 2015;24(12):2513-25. (PMID: 25608278)
ACS Appl Mater Interfaces. 2018 May 30;10(21):17489-17507. (PMID: 29742896)
Langmuir. 2015 Oct 27;31(42):11709-16. (PMID: 26442631)
Biomed Microdevices. 2016 Jun;18(3):49. (PMID: 27215416)
Nanoscale. 2021 Jul 15;13(27):11808-11816. (PMID: 34227638)
Drug Dev Ind Pharm. 2003 Oct;29(9):967-79. (PMID: 14606661)
Nanotechnology. 2020 Jan 24;31(5):055301. (PMID: 31561237)
Indian J Pharm Sci. 2012 May;74(3):189-94. (PMID: 23440630)
ACS Appl Mater Interfaces. 2015 Feb 11;7(5):3398-405. (PMID: 25594664)
Pharm Res. 2017 Feb;34(2):427-437. (PMID: 27943014)
Nano Lett. 2015 Aug 12;15(8):5321-9. (PMID: 26042472)
Trends Pharmacol Sci. 2018 May;39(5):440-451. (PMID: 29534837)
Int J Pharm. 2016 Jul 25;509(1-2):518-527. (PMID: 26541301)
معلومات مُعتمدة: RUDN University Strategic Academic Leadership Program RUDN
فهرسة مساهمة: Keywords: 2D printing; 3D printing; 4D printing; additive production; dosage formulations; inkjet printing; polymers; smart polymers
تواريخ الأحداث: Date Created: 20220709 Latest Revision: 20220716
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC9269197
DOI: 10.3390/polym14132543
PMID: 35808591
قاعدة البيانات: MEDLINE
الوصف
تدمد:2073-4360
DOI:10.3390/polym14132543